Details of the Drug

General Information of Drug (ID: DM0BCT7)

Drug Name
DTRI-031
Synonyms BB-031
Indication
Disease Entry ICD 11 Status REF
Ischemic stroke 8B11.5Z Phase 1 [1]
Cross-matching ID
TTD ID
DYZ76K

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
von Willebrand factor (VWF) TT3SZBT VWF_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Ischemic stroke
ICD Disease Classification 8B11.5Z
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
von Willebrand factor (VWF) DTT VWF 2.96E-01 2.47 2.08
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05005520) A Randomized, Double-Blind, Single-Center, Placebo-Controlled Phase 1 Study to Evaluate the Safety, Tolerability, PK and PD of Intravenous DTRI-031 in Healthy Volunteers. U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of Basking Biosciences